Aspen Pharmacare was due to release the first 1.1-million doses of the Johnson & Johnson's (J&J) coronavirus vaccine for the South African market this weekend, coinciding with the resumption of the vaccine rollout after it was temporarily halted.
Stavros Nicolaou, Aspen's senior executive for strategic trade, this week confirmed the first 1.1-million doses that were due for release on 24 April will be for SA...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.